Noor-E-Such Herbal Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth 91.82%
- Profit Growth 92.08%
- Ebitda -12.41%
- Net Worth 5.84%
- Total Assets 10.16%
About Noor-E-Such Herbal
Noor-E-Such Herbal Private Limited (NHPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 December 2004 and has a history of 20 years and one month. Its registered office is in Ghaziabad, Uttar Pradesh.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Nusrat Sultana and Mohammad Shakir serve as directors at the Company.
Company Details
- LocationGhaziabad, Uttar Pradesh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U52310UP2004PTC029380
- Company No.
029380
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Noor-E-Such Herbal?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nusrat Sultana  | Director | 30-Dec-2004 | Current |
| Mohammad Shakir | Additional Director | 22-Dec-2022 | Current |
Financial Performance of Noor-E-Such Herbal.
Noor-E-Such Herbal Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 91.82% increase. The company also saw a substantial improvement in profitability, with a 92.08% increase in profit. The company's net worth moved up by a moderate rise of 5.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Noor-E-Such Herbal?
Unlock access to Noor-E-Such Herbal's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2019 | Others | ₹1.00 M | Open |
How Many Employees Work at Noor-E-Such Herbal?
Unlock and access historical data on people associated with Noor-E-Such Herbal, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Noor-E-Such Herbal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noor-E-Such Herbal's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
